Working inside and outside traditional drug discovery
Nanomedicines could replace therapeutic antibodies (Debesh) or be used as a preventative against viral or bacterial infections.
I’ve previously discussed the new types of businesses being built in biology. One of the segments I highlighted were nanomedicines, which are able to reduce viral transmission of COVID and STI’s. However, their prominence is increasing with expanded technologies and use-cases. With this article, I plan to cover the main types of nanomedicines, their current status, and future potential.
Nanomedicine is the technology that is underpinning RNA and DNA therapeutics and vaccines by allowing for the cargo delivery to a certain cell type. The most common use case of nanomedicines is in drug delivery, primarily through lipid nanoparticles or liposomes. (Exosomes are also of interest but harder to generate due to the our reliance on cells to produce exosomes).
